Lifecore Biomedical, Inc.
LFCR · NASDAQ
9/30/2025 | 5/25/2025 | 2/23/2025 | 11/24/2024 | |
|---|---|---|---|---|
| Market Cap | – | $249 | $207 | $256 |
| - Cash | $19 | $8 | $5 | $9 |
| + Debt | $136 | $131 | $130 | $131 |
| Enterprise Value | – | $371 | $332 | $378 |
| Revenue | $31 | $36 | $35 | $33 |
| % Growth | -14.6% | 3.7% | 8% | – |
| Gross Profit | $8 | $14 | $10 | $11 |
| % Margin | 25% | 38.4% | 28% | 34% |
| EBITDA | -$7 | $6 | -$7 | $1 |
| % Margin | -22.9% | 17.3% | -20.5% | 3% |
| Net Income | -$10 | -$1 | -$15 | -$7 |
| % Margin | -32.1% | -3.1% | -42% | -20.2% |
| EPS Diluted | -0.29 | -0.055 | -0.47 | -0.25 |
| % Growth | -424.4% | 88.2% | -88% | – |
| Operating Cash Flow | $2 | $5 | $1 | -$6 |
| Capital Expenditures | -$2 | -$2 | -$5 | -$2 |
| Free Cash Flow | $0 | $3 | -$4 | -$9 |